David Cole to Macrophage Colony-Stimulating Factor
This is a "connection" page, showing publications David Cole has written about Macrophage Colony-Stimulating Factor.
Connection Strength
0.142
-
Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. J Natl Cancer Inst. 1994 Jan 05; 86(1):39-45.
Score: 0.111
-
Ex vivo effects of macrophage colony-stimulating factor on human monocyte activity against fungal and bacterial pathogens. Cytokine. 1996 Jan; 8(1):42-8.
Score: 0.032